Search

everythinglearnresearchcommunity

for

Search:↓

New compounds were made and tested, with compound 6 showing potential for treating prostate-related diseases.

A new compound was made that might help treat diseases related to male hormones.

Some synthesized compounds were more effective than Finasteride in reducing prostate cancer cell growth and androgen levels.

The chemicals 17βC and its methyl ester can block the effects of testosterone on hamster skin but not the effects of DHT.

Compound 7b is a promising candidate for treating benign prostatic hyperplasia and prostate cancer.

New chemical compounds were made that effectively block an enzyme linked to prostate growth.

A new method to make finasteride for hair loss treatment was developed.

Three compounds were found to inhibit a prostate disease-related enzyme and reduce prostate size more effectively than the current treatment, suggesting they could be used for treating benign prostatic hyperplasia.

A new method was developed to make a compound used in finasteride and epristeride with a 69% yield.

The new compounds moderately block a specific enzyme and strongly counteract a male hormone, suggesting potential for treating certain male-related health conditions.

The research found that compound 6, a newly created steroid, is more effective at inhibiting 5α-reductase (an enzyme) than current treatments, suggesting it could be a better option for treating urinary tract symptoms in men.

A new compound effectively inhibits human 5α-reductase 1.

New compounds with carborane showed anti-androgen effects similar to flutamide.

New compounds were made that effectively block a specific enzyme related to androgen conditions.

New A-homo-B, 19-dinor steroids showed strong antiandrogenic activity without affecting the enzyme 5α-reductase or androgen receptor binding.

Analog 23 is a promising compound for prostate cancer treatment.

CB-03-04 shows promise as a treatment for prostate issues due to its strong anti-androgen effects.

Some new progesterone derivatives are better at blocking testosterone conversion than a common drug.

Certain derivatives are more effective 5α-reductase type 2 inhibitors than finasteride.

The new method makes finasteride cheaper and easier to produce.

New pregnane derivatives were more effective than finasteride at inhibiting a key enzyme for male pattern baldness.

Adding cerium(III) chloride to Grignard reagents improves the making of compounds that could treat prostate issues and hair loss.

Researchers found new potential treatments for conditions related to the androgen receptor, like male hormonal contraception, by testing thousands of compounds.

The research shows that hydrogen bonds greatly affect the crystal structure of a Finasteride derivative.

New steroids were effective in blocking male hormone receptors in hamster prostates.

New nonsteroidal molecules can potentially increase dihydrotestosterone in neurons by blocking certain enzymes, without affecting prostate and seminal vesicle weight.

Finasteride was successfully synthesized from Pregnadienolone acetate.

Testosterone increases 3α-androstanediol levels, which can be blocked by finasteride.

A new method to make Finasteride is more cost-effective and yields 16%.